A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients

M Kilercik, Ö Demirelce, MA Serdar, P Mikailova… - PloS one, 2021 - journals.plos.org
Introduction Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 virus, is a major
public health concern spanning from healthy carriers to patients with life-threatening …

[HTML][HTML] Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters

C Wang, R Deng, L Gou, Z Fu, X Zhang… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background The third fatal coronavirus is the novel coronavirus (SARS-CoV-2) that causes
novel coronavirus pneumonia (COVID-19) which first broke out in December 2019. Patients …

Evaluation of hematological parameters as an indicator of disease severity in Covid‐19 patients: Pakistan's experience

A Waris, M Din, A Khalid, R Abbas Lail… - Journal of Clinical …, 2021 - Wiley Online Library
Background The severity of COVID‐19 could be evaluated by examining several blood
parameters mainly white blood cell (WBC) count, granulocytes, platelet, and novel …

Logistic regression analysis to predict mortality risk in COVID-19 patients from routine hematologic parameters

S Bhandari, A Shaktawat, A Tak, B Patel… - Ibnosina Journal of …, 2020 - thieme-connect.com
Background: The triage of coronavirus-19 patients into various strata based on some
prognostic indicator might prove a utilitarian strategy in the management of epidemic. The …

[HTML][HTML] Association of Hematologic biomarkers and their combinations with disease severity and mortality in COVID-19-an Indian perspective

M Pujani, S Raychaudhuri, N Verma… - American journal of …, 2021 - ncbi.nlm.nih.gov
Background: COVID-19 is a systemic viral infection with a significant impact on the
hematopoietic system, hemostasis as well as immune system. It would be of utmost …

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study

Y Zheng, Y Zhang, H Chi, S Chen, M Peng… - Clinical Chemistry and …, 2020 - degruyter.com
Abstract Objectives In December 2019, there was an outbreak of coronavirus disease 2019
(COVID-19) in Wuhan, China, and since then, the disease has been increasingly spread …

Can hematological ratios predict outcome of COVID-19 patients? A multicentric study

MM Aly, TS Meshref, MA Abdelhameid… - Journal of Blood …, 2021 - Taylor & Francis
Introduction Coronaviruses belong to a large family that leads to respiratory infection of
various severity. Hematological ratios are indicators of inflammatory response widely used …

[HTML][HTML] Complete blood cells count abnormalities in COVID-19 patients and their prognostic significance: single center study in Makkah, Saudi Arabia

AE Abd El-Lateef, MM Ismail, G Thabet… - Saudi Medical …, 2022 - ncbi.nlm.nih.gov
Objectives: To evaluate the role of different peripheral blood count parameters as a cheap
and rapid test in determination of coronavirus disease-19 (COVID-19) severity and patients' …

Characteristics of peripheral blood differential counts in hospitalized patients with COVID‐19

IS Pakos, KB Lo, G Salacup, J Pelayo… - European journal of …, 2020 - Wiley Online Library
Background A lot remains unknown about the features and laboratory findings that may
predict worse outcomes in patients with coronavirus disease 2019 (COVID‐19). The aim of …

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

J Linssen, A Ermens, M Berrevoets, M Seghezzi… - Elife, 2020 - elifesciences.org
COVID-19 induces haemocytometric changes. Complete blood count changes, including
new cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 …